JP7206223B2 - パーキンソン病の予防および／または支持治療処置のための物質 - Google Patents

パーキンソン病の予防および／または支持治療処置のための物質 Download PDF

Info

Publication number
JP7206223B2
JP7206223B2 JP2019571280A JP2019571280A JP7206223B2 JP 7206223 B2 JP7206223 B2 JP 7206223B2 JP 2019571280 A JP2019571280 A JP 2019571280A JP 2019571280 A JP2019571280 A JP 2019571280A JP 7206223 B2 JP7206223 B2 JP 7206223B2
Authority
JP
Japan
Prior art keywords
butyric acid
propionic acid
physiologically acceptable
disease
parkinson
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2019571280A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020526485A5 (https=
JP2020526485A (ja
Inventor
プルツンテク ホルスト
ハギキア アイデン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aiden Haghikia
Horst Przuntek
Original Assignee
Aiden Haghikia
Horst Przuntek
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aiden Haghikia, Horst Przuntek filed Critical Aiden Haghikia
Publication of JP2020526485A publication Critical patent/JP2020526485A/ja
Publication of JP2020526485A5 publication Critical patent/JP2020526485A5/ja
Application granted granted Critical
Publication of JP7206223B2 publication Critical patent/JP7206223B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/322—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/02—Acid
    • A23V2250/05—Propionic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
JP2019571280A 2017-07-13 2018-07-13 パーキンソン病の予防および／または支持治療処置のための物質 Active JP7206223B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102017115819.7A DE102017115819A1 (de) 2017-07-13 2017-07-13 Mittel zur prophylaktischen und/oder unterstützenden therapeutischen Behandlung von Morbus Parkinson
DE102017115819.7 2017-07-13
PCT/EP2018/069089 WO2019012108A1 (de) 2017-07-13 2018-07-13 Propion- und/oder buttersäure zur verwendung zur prophylaktischen und/oder unterstützenden therapeutischen behandlung von morbus parkinson

Publications (3)

Publication Number Publication Date
JP2020526485A JP2020526485A (ja) 2020-08-31
JP2020526485A5 JP2020526485A5 (https=) 2021-02-04
JP7206223B2 true JP7206223B2 (ja) 2023-01-17

Family

ID=63108510

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019571280A Active JP7206223B2 (ja) 2017-07-13 2018-07-13 パーキンソン病の予防および／または支持治療処置のための物質

Country Status (10)

Country Link
US (2) US20200163914A1 (https=)
EP (1) EP3651754B1 (https=)
JP (1) JP7206223B2 (https=)
KR (1) KR20200027976A (https=)
CN (1) CN110996933A (https=)
AU (2) AU2018298862A1 (https=)
BR (1) BR112020000570A2 (https=)
CA (1) CA3067728A1 (https=)
DE (1) DE102017115819A1 (https=)
WO (1) WO2019012108A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021048440A1 (en) 2019-09-13 2021-03-18 Basf Se Composition for the treatment of neurodegenerative diseases
CN111450238A (zh) * 2020-03-31 2020-07-28 上海交通大学医学院附属瑞金医院 骨钙素或丙酸在制备抗帕金森病药物中的应用
CN113332266A (zh) * 2021-06-10 2021-09-03 徐州医科大学 含丁酸的治疗与预防神经退行性疾病的药物及丁酸的应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016530239A (ja) 2013-07-09 2016-09-29 ピュアテック ベンチャーズ、エルエルシー 微生物叢由来生物活性分子の組み合わせを含む疾患治療用組成物
WO2017067681A1 (de) 2015-10-19 2017-04-27 Flexopharm Brain Gmbh & Co. Kg Mittel zur unterstützenden immunmodulation
WO2017091072A1 (en) 2015-11-27 2017-06-01 Birrbeheer B.V. Butyrate salts for use in inflammatory diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19503598A1 (de) * 1995-02-03 1996-08-08 Zuzana Dr Cully Verfahren zur fermentativen Herstellung von Propionsäure oder Buttersäure bzw. deren Salze
NL1009990C2 (nl) * 1998-09-02 2000-03-15 Sibeco Chemicals Voedingssupplement en werkwijze voor het vervaardigen van zulk voedingssupplement.
US20060105962A1 (en) * 2004-11-14 2006-05-18 Robinson Robert O A Tonic to maintain intestinal flora
EP2538804B1 (de) * 2011-01-12 2015-04-15 Albert Daxer Getränk
CN105055457A (zh) * 2015-08-06 2015-11-18 温州医科大学附属第二医院 一种防治阿尔茨海默病的药物及其制备方法和应用
US11065217B2 (en) * 2017-01-27 2021-07-20 Temple University—Of the Commonwealth System of Higher Education Use of short chain fatty acids for the treatment and prevention of diseases and disorders

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016530239A (ja) 2013-07-09 2016-09-29 ピュアテック ベンチャーズ、エルエルシー 微生物叢由来生物活性分子の組み合わせを含む疾患治療用組成物
WO2017067681A1 (de) 2015-10-19 2017-04-27 Flexopharm Brain Gmbh & Co. Kg Mittel zur unterstützenden immunmodulation
WO2017091072A1 (en) 2015-11-27 2017-06-01 Birrbeheer B.V. Butyrate salts for use in inflammatory diseases

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Neurochemistry International，2016年，Vol. 95，pp. 75-84

Also Published As

Publication number Publication date
AU2021273627A1 (en) 2021-12-16
WO2019012108A1 (de) 2019-01-17
AU2018298862A1 (en) 2020-01-23
DE102017115819A1 (de) 2019-01-17
EP3651754C0 (de) 2025-04-30
KR20200027976A (ko) 2020-03-13
AU2021273627B2 (en) 2024-01-25
CA3067728A1 (en) 2019-01-17
EP3651754B1 (de) 2025-04-30
CN110996933A (zh) 2020-04-10
BR112020000570A2 (pt) 2020-07-14
EP3651754A1 (de) 2020-05-20
US20220313634A1 (en) 2022-10-06
US20200163914A1 (en) 2020-05-28
JP2020526485A (ja) 2020-08-31

Similar Documents

Publication Publication Date Title
US11471432B2 (en) Supporting immunomodulatory agent
AU2021273627B2 (en) Agent for the prophylactic and/or supportive therapeutic treatment of Parkinson's disease
US20200289442A1 (en) Supporting immunomodulatory agent
WO2001087291A1 (fr) Compositions permettant de regulariser le rythme circadien
EA025256B1 (ru) Композиция, подходящая для лечения нарушений липидного обмена
JP2017525771A (ja) 体重と体脂肪減少に用いられる組成物およびその医薬品と使用
JP2007238441A (ja) アスタキサンチンを有効成分とする体脂肪減少用組成物
US11304923B2 (en) Use of a benzoate containing composition to treat glycine encephalopathy
US8557236B2 (en) Cardiovascular support supplement and compositions and methods thereof
NO20001717L (no) Serotonin-inneholdende formulering for oral administrering og anvendelse av samme
US11596166B2 (en) Compositions and methods for treating aging and/or improving human health
US11458150B2 (en) Methylphosphinic acid compositions and methods for reducing aging
JP6594858B2 (ja) メラトニン分泌調整剤、メラトニン分泌調整方法
JPWO2009054360A1 (ja) 内臓脂肪特異的低減剤
US20180193312A1 (en) Nutraceutical composition and dosing regimen
TWI735658B (zh) 用於減少代謝症候群之組合物及其應用
TW201618767A (zh) 治療不寧腿症候群及腿痙攣的組成物及方法
JPH02142732A (ja) 肥満並びに肥満に関連する各種疾患の治療剤
CN120731089A (zh) 末梢神经障碍的治疗或预防用医药品
CN102526088A (zh) 维生素b12口服制剂的改进配方及用途
JP2009531306A5 (https=)
JP2009173605A (ja) 医薬組成物

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20201215

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20201215

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20210915

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20210921

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20211221

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20220217

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220311

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220715

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220922

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20221021

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20221116

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20221206

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20230104

R150 Certificate of patent or registration of utility model

Ref document number: 7206223

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250